From: Ezrin promotes invasion and metastasis of pancreatic cancer cells
variable | No. of patients | ezrin expression | P* | |
---|---|---|---|---|
 |  | positive(n = 64) | negative(n = 6) |  |
Age | Â | Â | Â | 0.175 |
< 65 | 53 | 47 | 6 | Â |
> 65 | 17 | 17 | 0 | Â |
Gender | Â | Â | Â | 0.34 |
Male | 45 | 41 | 4 | Â |
Female | 25 | 23 | 2 | Â |
Histopathogic grading | Â | Â | 0.4688 | |
G1 | 8 | 8 | 0 | Â |
G2 | 38 | 34 | 4 | Â |
G3 | 24 | 22 | 2 | Â |
Depth of invasion | Â | Â | 0.653 | |
T1 | 2 | 2 | 0 | Â |
T2 | 17 | 15 | 8 | Â |
T3 | 46 | 42 | 4 | Â |
T4 | 5 | 5 | 0 | Â |
Pathologic stage | Â | Â | 0.249 | |
I | 5 | 5 | 0 | Â |
II | 16 | 14 | 2 | Â |
III | 41 | 39 | 23 | Â |
IV | 8 | 6 | 2 | Â |
LN metastasis | Â | Â | Â | 0.3304 |
Negative | 27 | 25 | 2 | Â |
Positive | 43 | 39 | 4 | Â |